These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13817945)

  • 21. [BIOLOGICAL DEFENSE OF BCG-VACCINATED ANIMALS, WITH SPECIAL REFERENCE TO THE EFFECTS OF INAH AND STEROIDS ON BODY FLUIDS].
    UCHIDA T
    Nihon Shonika Gakkai Zasshi; 1964 Jul; 68():537-44. PubMed ID: 14181121
    [No Abstract]   [Full Text] [Related]  

  • 22. [TUBERCULIN REACTION IN CALFS AFTER VACCINATION WITH BCG VACCINES BOTH SENSITIVE AND RESISTANT TO STREPTOMYCIN AND ISONICOTINIC ACID HYDRAZIDE AND AFTER INFECTION WITH BOVINE BACILLUS DURING INH PREVENTIVE TREATMENT].
    BURACZEWSKI O; OSINSKI J
    Gruzlica (1926); 1964 Sep; 32():773-80. PubMed ID: 14249994
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rifampicin-resistant Mycobacterium bovis BCG strain isolated from an infant with NEMO mutation].
    Çavuşoğlu C; Edeer Karaca N; Azarsız E; Ulusoy E; Kütükçüler N
    Mikrobiyol Bul; 2015 Apr; 49(2):272-7. PubMed ID: 26167828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunizing properties of an isoniazid-resistant mutant of the Vallée strain of M. tuberculosis as compared with BCG; observations in the mouse and guinea pig.
    HOBBY GL; LENERT TF; AUERBACH O
    Am Rev Tuberc; 1954 Sep; 70(3):527-30. PubMed ID: 13189070
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative study of the vaccinating properties of BCG and its isoniazid-resistant mutant in guinea pigs.
    SCHAEFER WB; COHN ML; MIDDLEBROOK G
    Am Rev Tuberc; 1957 Apr; 75(4):656-8. PubMed ID: 13411425
    [No Abstract]   [Full Text] [Related]  

  • 26. [RELATIONSHIP BETWEEN CANCER AND TUBERCULOSIS. 2). A RETARDING EFFECT OF BCG INOCULATION FOR TUMOR INDUCTION IN MICE WITH INH OR URETHANE-4 NQO INJECTIONS].
    HATTORI S; MATSUDA M
    Kekkaku; 1964 Oct; 39():449-52. PubMed ID: 14271996
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental study in animal and man of B.C.G. resistant to isoniazid].
    GERNEZ-RIEUX C; TACQUET A; GAUDIER B
    Ann Inst Pasteur Lille; 1961; 12():63-74. PubMed ID: 13960536
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver.
    Balazuc AM; Lagranderie M; Chavarot P; Pescher P; Roseeuw E; Schacht E; Domurado D; Marchal G
    Microbes Infect; 2005 Jun; 7(7-8):969-75. PubMed ID: 15994108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The uptake and fate of isoniazid in Mycobacterium tuberculosis var. bovis BCG.
    Wimpenny JW
    J Gen Microbiol; 1967 Jun; 47(3):389-403. PubMed ID: 5340775
    [No Abstract]   [Full Text] [Related]  

  • 30. [TUBERCULIN AS AN ADDITIONAL FACTOR IN THE HEALING PROCESS IN TUBERCULOSIS].
    MIRZOIAN EZ; OSINTSEVA VP
    Arkh Patol; 1964; 26():30-6. PubMed ID: 14182489
    [No Abstract]   [Full Text] [Related]  

  • 31. [The tricarboxylic acid cycle in attenuated Mycobacterium tuberculosis (BCG) and its variants resistant to streptomycin, PAS and isonicotinic acid hydrazide].
    SORU E; ISTRATI M; SZABADOS J; TANASESCO D; PARASCHIVESCO M
    Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():637-50. PubMed ID: 13915330
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies of anti-tuberculous effect of phthivaside].
    ZEBROWSKI T; PIENIAZEK J; TROJANOWSKI S; BOROWIECKA A
    Pol Tyg Lek (Wars); 1957 Sep; 12(36):1390-3. PubMed ID: 13505232
    [No Abstract]   [Full Text] [Related]  

  • 33. [COMPARISON OF TUBERCULIN REACTION OF CHILDREN VACCINATED WITH BCG (MOREAU) VACCINE AND BCG VACCINE SENSITIVE AND RESISTANT TO INH AND STREPTOMYCIN].
    KRZYSZKOWSKA A
    Gruzlica (1926); 1964 Sep; 32():789-95. PubMed ID: 14249996
    [No Abstract]   [Full Text] [Related]  

  • 34. [SELECTIVE VACCINATION WITH ISONIAZID-RESISTANT BCG IN THE TOWN OF SONDALO].
    PARRAVICINI C; BETTINI L; PALATRESI R; RAMPINI GF
    G Ital Tuberc Mal Torace; 1963; 17():192-6. PubMed ID: 14089691
    [No Abstract]   [Full Text] [Related]  

  • 35. [VACCINAL POWER IN THE GUINEA PIG OF INH-RESISTANT BCG AND INH-RESISTANT BCG "LABELED" WITH RESISTANCE TO GRAMICIDIN].
    AUGIER J; BRETEY J; AUGIER-GIBORY S; BOISVERT H
    Ann Inst Pasteur (Paris); 1963 Nov; 105():937-48. PubMed ID: 14098103
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of isoniazid by Mycobacterium tuberculosis BCG with reference to current theories of the mode of action.
    YOUATT J
    Am Rev Tuberc; 1958 Nov; 78(5):806-9. PubMed ID: 13583450
    [No Abstract]   [Full Text] [Related]  

  • 37. THE IMMUNOGENICITY OF BCG (PHIPPS) AND ITS ISONIAZID-RESISTANT MUTANT IN GUINEA PIGS SIMULTANEOUSLY VACCINATED, INFECTED, AND TREATED.
    DWORSKI M
    Am Rev Respir Dis; 1964 Jul; 90():97-104. PubMed ID: 14180060
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pattern of a test with isoniazid-resistant BCG in a strongly tuberculinized environment].
    Baroni V; Giaconi G
    G Ital Mal Torace; 1969; ():Suppl 1:56-8. PubMed ID: 4893882
    [No Abstract]   [Full Text] [Related]  

  • 39. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer.
    Watts MR; Taylor PC; Sintchenko V; Whelan CM; Farnsworth RH; Jones P; Jelfs P; Carr D; Goldberg H
    Clin Infect Dis; 2011 Jan; 52(1):86-8. PubMed ID: 21148524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [STUDIES ON A HYDRAZIDE-RESISTANT STRAIN OF BCG MOREAU. III. VIRULENCE IN ANIMALS AND SOME PHYSIOLOGICAL CHARACTERISTICS].
    SITEK K
    Med Dosw Mikrobiol; 1963; 15():207-16. PubMed ID: 14062753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.